Table 1.
BT474 wt vs. Tz-R | MDA-MB-361 wt vs. Tz-R | SKBR-3 wt vs. Tz-R | ||||||
---|---|---|---|---|---|---|---|---|
KEGG Pathway | % of DEPs | p-Value | KEGG Pathway | % of DEPs | p-Value | KEGG Pathway | % of DEPs | p-Value |
Metabolic pathways | 18.6 | 5.00 × 10−5 | Chronic myeloid leukemia | 2.9 | 1.40 × 10−2 | Metabolic pathways | 28 | 7.00 × 10−3 |
Biosynthesis of cofactors | 4.3 | 5.00 × 10−3 | TGF-beta signaling pathway | 2.9 | 2.50 × 10−2 | Thyroid hormone signaling pathway | 6 | 1.10 × 10−2 |
Metabolic pathways | 17 | 4.30 × 10−2 | Glycerophospholipid metabolism | 5 | 2.40 × 10−2 | |||
Proteoglycans in cancer | 5 | 4.90 × 10−2 |